Resolvin d1

Resolvin d1 is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 305 references associated with Resolvin d1 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Resolvin d1

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Resolvin d1

PubChem Biomolecular Interactions and Pathways

All references with Resolvin d1

Download all related citations
Per page 10 20 50 100 | Total 185
Authors Title Published Journal PubMed Link
Widgerow AD Cellular resolution of inflammation--catabasis. 2012 Jan-Feb Wound Repair Regen pmid:22276585
Ji RR et al. Emerging roles of resolvins in the resolution of inflammation and pain. 2011 Trends Neurosci. pmid:21963090
Ariel A and Serhan CN Resolvins and protectins in the termination program of acute inflammation. 2007 Trends Immunol. pmid:17337246
Chen J et al. Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury. 2014 Toxicol. Appl. Pharmacol. pmid:24709673
Dalli J et al. Novel n-3 immunoresolvents: structures and actions. 2013 Sci Rep pmid:23736886
Wang CS et al. ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland. 2016 Sci Rep pmid:27064029
Liao Z et al. Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. 2012 Respir. Res. pmid:23199346
Wang B et al. Resolvin D1 protects mice from LPS-induced acute lung injury. 2011 Pulm Pharmacol Ther pmid:21501693
Recchiuti A Resolvin D1 and its GPCRs in resolution circuits of inflammation. 2013 Prostaglandins Other Lipid Mediat. pmid:23500003
Serhan CN et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. 2004 Prostaglandins Other Lipid Mediat. pmid:15290791
Yuan J et al. The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro. 2010 Prostaglandins Other Lipid Mediat. pmid:20394833
Shi H et al. VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1. 2016 Prostaglandins Other Lipid Mediat. pmid:27026343
Levy BD Resolvins and protectins: natural pharmacophores for resolution biology. 2010 Apr-Jun Prostaglandins Leukot. Essent. Fatty Acids pmid:20227865
Marcheselli VL et al. Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. 2010 Prostaglandins Leukot. Essent. Fatty Acids pmid:19931440
Krishnamoorthy S et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20080636
Jones CN et al. Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:23185003
Fredman G et al. Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25246560
Cox R et al. Resolvins Decrease Oxidative Stress Mediated Macrophage and Epithelial Cell Interaction through Decreased Cytokine Secretion. 2015 PLoS ONE pmid:26317859
Wales KM et al. N-3 PUFAs protect against aortic inflammation and oxidative stress in angiotensin II-infused apolipoprotein E-/- mice. 2014 PLoS ONE pmid:25398022
Abdelmoaty S et al. Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release. 2013 PLoS ONE pmid:24086560
Martin CR et al. Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury. 2014 PLoS ONE pmid:24892762
Hsiao HM et al. A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation. 2013 PLoS ONE pmid:23484005
Martin N et al. Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation. 2012 PLoS ONE pmid:22970103
Zhang X et al. Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3β acetylation. 2013 PLoS ONE pmid:23840712
Sun YB et al. Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney. 2013 PLoS ONE pmid:24391884
Lee Y et al. Analysis of endogenous lipids during intestinal wound healing. 2017 PLoS ONE pmid:28800645
Mottola G et al. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway. 2017 PLoS ONE pmid:28362840
Eickmeier O et al. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. 2017 PLoS ONE pmid:28158236
Easley JT et al. AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epithelium. 2016 Physiol Rep pmid:27694530
Huang L et al. Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. 2011 Pain pmid:21255928
Zhang X et al. Resolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating IκBα signaling in human vascular endothelial cells. 2013 Oxid Med Cell Longev pmid:24381712
Chiang N et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. 2012 Nature pmid:22538616
Sommer C and Birklein F Fighting off pain with resolvins. 2010 Nat. Med. pmid:20448572
Xu ZZ et al. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. 2010 Nat. Med. pmid:20383154
Maekawa T et al. Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway. 2015 Nat Commun pmid:26374165
Abdulnour RE et al. Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation. 2016 Mucosal Immunol pmid:26647716
Eickmeier O et al. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. 2013 Mucosal Immunol pmid:22785226
Li D et al. Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion. 2013 Mucosal Immunol pmid:23462912
Rossi S et al. Interplay between Intravitreal RvD1 and Local Endogenous Sirtuin-1 in the Protection from Endotoxin-Induced Uveitis in Rats. 2015 Mediators Inflamm. pmid:26180376
Rossi S et al. Protection from endotoxic uveitis by intravitreal Resolvin D1: involvement of lymphocytes, miRNAs, ubiquitin-proteasome, and M1/M2 macrophages. 2015 Mediators Inflamm. pmid:25684860
Wu D et al. Novel biphasic role of resolvin D1 on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts is partly through PI3K/AKT and ERK2 pathways. 2013 Mediators Inflamm. pmid:24174713
Settimio R et al. Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis. 2012 Mediators Inflamm. pmid:23304060
Chen Y et al. Endogenous pro-resolving and anti-inflammatory lipid mediators: the new hope of atherosclerotic diseases. 2008 Med. Hypotheses pmid:18448265
Gilbert K et al. Resolvin D1, a metabolite of omega-3 polyunsaturated fatty acid, decreases post-myocardial infarct depression. 2014 Mar Drugs pmid:25402828
Xie W et al. ResolvinD1 reduces apoptosis and inflammation in primary human alveolar epithelial type 2 cells. 2016 Lab. Invest. pmid:26878131
Xie W et al. Resolvin D1 reduces deterioration of tight junction proteins by upregulating HO-1 in LPS-induced mice. 2013 Lab. Invest. pmid:23857007
Yaxin W et al. Resolvin D1 attenuates lipopolysaccharide induced acute lung injury through CXCL-12/CXCR4 pathway. 2014 J. Surg. Res. pmid:24387839
Khaled M et al. Effects of resolvin D1 on cell survival and cytokine expression of human gingival fibroblasts. 2013 J. Periodontol. pmid:23398023
Serhan CN Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators. 2008 J. Periodontol. pmid:18673006
Park CK et al. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. 2011 J. Neurosci. pmid:22171045

Table of Content